Frede N. Donskov

Palle Juul Jensens Blvd. 99
Aarhus N, 8200, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 162 publications

Involving patient partners as appraisers of shared decision making: an explanatory sequential mixed-methods study.

Involving patient partners as appraisers of shared decision making: an explanatory sequential mixed-methods study.

Journal: Research involvement and engagement

Published: March 29, 2026

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma.

International metastatic renal cell carcinoma database consortium classification and regression tree analysis to characterize objective response rates to first line in metastatic renal cell carcinoma.

Journal: Frontiers in oncology

Published: March 10, 2026

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Outcomes of Complete Responders From First-line Therapy in Metastatic Renal Cell Carcinoma in the Real World: An Analysis From the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: Clinical genitourinary cancer

Published: January 15, 2026

Navigating the cancer trajectory in colorectal cancer: perceptions of cure over care, efficiency, and limited emotional support.

Navigating the cancer trajectory in colorectal cancer: perceptions of cure over care, efficiency, and limited emotional support.

Journal: Journal of cancer survivorship : research and practice

Published: November 18, 2025

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.

Nivolumab plus ipilimumab versus sunitinib for first-line treatment of advanced renal cell carcinoma: final analysis of efficacy and safety from the phase III CheckMate 214 trial.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: November 14, 2025

Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC).

Attrition Rates in Metastatic Renal Cell Carcinoma (mRCC) Following First Line Immunotherapy-Based Treatment: Results From the International mRCC Database Consortium (IMDC).

Journal: Clinical genitourinary cancer

Published: October 29, 2025

Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Outcomes of Patients with Metastatic Non-clear Cell Renal Cell Carcinoma Receiving Contemporary or Traditional First-line Therapies: Results from the International Metastatic Renal Cell Carcinoma Database Consortium.

Journal: European urology oncology

Published: August 23, 2025

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Therapeutic drug monitoring (TDM) of tyrosine kinase inhibitors (TKI) for optimized outcome in patients with metastatic renal cell carcinoma. The TKI-TDM Trial. Study protocol.

Journal: Acta oncologica (Stockholm, Sweden)

Published: April 23, 2025

Compassion training for healthcare professionals in oncology: A mixed-methods pilot study.

Compassion training for healthcare professionals in oncology: A mixed-methods pilot study.

Journal: European journal of oncology nursing : the official journal of European Oncology Nursing Society

Published: November 19, 2024

Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials.

Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials.

Journal: Current oncology reports

Published: November 09, 2024

Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group.

Outcomes based on risk-adapted adjuvant therapy in postmenopausal women with early breast cancer: a nationwide, prospective cohort study by the Danish Breast Cancer Group.

Journal: The Lancet. Oncology

Published: August 27, 2024

Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism.

Cabozantinib Induces Isolated Hyperbilirubinemia in Renal Cell Carcinoma Patients carrying the UGT1A1*28 Polymorphism.

Journal: Clinical genitourinary cancer

Published: July 08, 2024

Showing 1-12 of 162

Last Updated: 09/26/2026